2009
DOI: 10.1002/ajmg.a.33075
|View full text |Cite
|
Sign up to set email alerts
|

Clinical problems and everyday abilities of a group of Italian adolescent and young adults with Cornelia de Lange syndrome

Abstract: Cornelia de Lange syndrome (CdLS) is a multiple congenital anomaly/mental retardation syndrome, characterized by distinctive facial features, generalized hirsutism, growth and cognitive dysfunction, microcephaly and limb abnormalities. Currently mutations of three different genes, NIPBL, SMC1A, and SMC3, are known to be related to the CdLS phenotype with an overall detection rate of about 50%. Few data are available regarding the level of autonomy in everyday life of CdLS patients. Due to the collaboration of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
3
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 14 publications
0
11
3
2
Order By: Relevance
“…Hearing loss was reported for many of these patients, with sensorineural hearing loss affecting 40.3% (95% CI: 17.3–63.4), conductive hearing loss affecting 22.7% (95% CI: 5.7–39.7), and mixed or unspecified hearing loss affecting 34.5 (95% CI: 19.3–49.7) (Fig. ) . When hearing loss was present, it was mild in 30.4% (95% CI: 10.8–50.1), moderate in 18.1% (95% CI: 11.3–25.0), moderate to severe in 22.0% (95% CI: 8.4–35.7), severe in 21.9% (95% CI: 13.3–30.7), and profound in 29.4% (95% CI: 16.4–42.3).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Hearing loss was reported for many of these patients, with sensorineural hearing loss affecting 40.3% (95% CI: 17.3–63.4), conductive hearing loss affecting 22.7% (95% CI: 5.7–39.7), and mixed or unspecified hearing loss affecting 34.5 (95% CI: 19.3–49.7) (Fig. ) . When hearing loss was present, it was mild in 30.4% (95% CI: 10.8–50.1), moderate in 18.1% (95% CI: 11.3–25.0), moderate to severe in 22.0% (95% CI: 8.4–35.7), severe in 21.9% (95% CI: 13.3–30.7), and profound in 29.4% (95% CI: 16.4–42.3).…”
Section: Resultsmentioning
confidence: 99%
“…Twenty-five case series reported on otologic manifestations of CdLS (Table II). Hearing loss was reported for many of these patients, with sensorineural hearing loss affecting 40 2,5,[11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] Five case series reported on middle ear anomalies. 19,23,30,32 Ossicular chain anomalies affected 57.2% (42.3-72.1) of patients.…”
Section: Otologic Manifestationsmentioning
confidence: 99%
“…Mutation analyses were performed in six studies (14%). Nine papers mentioned medication use by participants (21%) . Limited specifics were provided regarding medication use, information ranged from ‘numerous medications’ and ‘antipsychotic medication’ to medication used for ‘hyperactivity, sleep problems, or aggressiveness’.…”
Section: Resultsmentioning
confidence: 99%
“…Few studies have investigated the needs and rights of inhomogeneous populations lacking a diagnosis although several studies exist concerning well-defined and homogeneous population such as Down syndrome [27–31], Williams syndrome, Fragile X syndrome, Autism [32, 33], Angelman, Cornelia de Lange [34] and Cri du Chat syndrome [21]. …”
Section: Discussionmentioning
confidence: 99%